Metabolic Syndrome and Prostate Cancer: a Review of Complex Interplay Amongst Various Endocrine Factors in the Pathophysiology and Progression of Prostate Cancer Handoo RheeIan VelaEric Chung Review 06 November 2015 Pages: 75 - 83
Moving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat Prostate Cancer Christopher FoleyNicholas Mitsiades Review 04 January 2016 Pages: 84 - 103
Classical and Non-Classical Roles for Pre-Receptor Control of DHT Metabolism in Prostate Cancer Progression Ailin ZhangJiawei ZhangElahe A. Mostaghel Review 21 January 2016 Pages: 104 - 113
Hsp90 Inhibition Results in Glucocorticoid Receptor Degradation in Association with Increased Sensitivity to Paclitaxel in Triple-Negative Breast Cancer Abena S. AgyemanWesley J. JunSuzanne D. Conzen Original Paper 08 February 2016 Pages: 114 - 126
Nipple Aspirate Fluid Hormone Concentrations and Breast Cancer Risk Robert T. ChattertonRichard E. HeinzSeema A. Khan Original Paper 22 February 2016 Pages: 127 - 136
Anti-Tumoral Effects of Anti-Progestins in a Patient-Derived Breast Cancer Xenograft Model Nathalie EsberClément CherbonnierNathalie Chabbert-Buffet Original Paper 03 March 2016 Pages: 137 - 147